hotspot
leisure time
explore
-
Ebola: Gilead Sciences antiviral shows promise as new treatment
2025-10-02 23:37 -
Bayer exec: U.S. is key in reviving beleaguered pharma’s drug pipeline
2025-10-02 23:14 -
AbbVie CEO Gonzalez to step down after a decade fiercely defending Humira
2025-10-02 23:03 -
Secretariat’s lessons for human medicine
2025-10-02 22:45 -
Readout Newsletter: Bristol, Sangamo, Gilead, and more
2025-10-02 22:29 -
Congress may force more Covid
2025-10-02 22:26